Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating and preventing chronic obstractive pneumonia

A technology for chronic obstructive and pulmonary disease, applied in pharmaceutical formulations, drug combinations, drug delivery, etc., can solve the problems of unsatisfactory use effect, toxic side effects, and unsatisfactory curative effects, and achieve no toxic side effects, strong preventive effect, and good Therapeutic and prophylactic effects

Inactive Publication Date: 2008-05-28
李原青
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although there are many medicines for the treatment of this disease at present, the problem of unsatisfactory curative effect generally exists, and most of the existing therapeutic medicines are western medicines. Although these western medicines have certain curative effects, they also have toxic and side effects. more serious
Therefore, the current treatment and prevention of chronic obstructive pulmonary disease drugs have the disadvantages of unsatisfactory use effect and certain toxic and side effects.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating and preventing chronic obstractive pneumonia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] Embodiment 1 of the present invention: take 30 grams of Astragalus membranaceus, 20 grams of Codonopsis pilosula, 10 grams of Dannanxing, and 10 grams of silkworm, and add 500 milliliters of water to fully mix it into a medicinal liquid, then boil the medicinal liquid according to the production process of a conventional oral liquid Concentrate to 100 milliliters, can make oral liquid preparation of the present invention. The method of taking the oral liquid preparation is as follows: 2-3 times a day, 10-20 milliliters each time, take it with warm boiled water.

Embodiment 2

[0017] Embodiment 2 of the present invention: take 20 grams of Astragalus membranaceus, 10 grams of Codonopsis pilosula, 15 grams of Dannanxing, and 15 grams of silkworm, and add 500 milliliters of water to fully mix it into a medicinal liquid, then boil the medicinal liquid according to the production process of a conventional oral liquid Concentrate to 100 milliliters, can make oral liquid preparation of the present invention. The method of taking the oral liquid preparation is as follows: 2-3 times a day, 10-20 milliliters each time, take it with warm boiled water.

Embodiment 3

[0018] Embodiment 3 of the present invention: take 10 grams of Astragalus membranaceus, 10 grams of Codonopsis pilosula, 5 grams of Dannanxing, and 10 grams of silkworm silkworm, and add 500 milliliters of water to fully mix it into a medicinal liquid, then boil the medicinal liquid according to the production process of conventional oral liquid Concentrate to 100 milliliters, can make oral liquid preparation of the present invention. The method of taking the oral liquid preparation is as follows: 2-3 times a day, 10-20 milliliters each time, take it with warm boiled water.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses a Chinese medicine for effectively curing and preventing chronic obstructive disease of lung with obvious therapeutic effect. It is made up by using (by weight portion) 1-30 portions of astragalus root, 1-20 portions of pilose asiabell root, 1-15 portions of bile-processed arisaema root and 1-15 portions of silkworm through a certain preparation process.

Description

Technical field: [0001] The invention relates to a medicine for treating and preventing chronic obstructive pulmonary disease. Background technique: [0002] Chronic Obstructive Pulmonary Disease (COPD) refers to diseases such as chronic bronchitis and / or emphysema with airflow obstruction characteristics. In recent years, this disease has become the main cause of chronic respiratory failure. Due to the slow progressive development of the disease, it seriously affects the patient's working ability and quality of life. Emphasis on the treatment of stable COPD is beneficial to delay the development of the disease. Although there are many medicines for the treatment of this disease at present, the problem of unsatisfactory curative effect generally exists, and most of the existing therapeutic medicines are western medicines. Although these western medicines have certain curative effects, they also have toxic and side effects. More serious. Therefore, the current treatment an...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/8884A61K36/481A61K36/344A61K35/64A61K9/08A61K9/10A61K9/16A61K9/20A61K9/48A61P11/00
Inventor 李原青
Owner 李原青
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products